Vandetanib
CAS No. 443913-73-3
Vandetanib ( ZD6474 )
Catalog No. M14519 CAS No. 443913-73-3
Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 41 | In Stock |
|
25MG | 57 | In Stock |
|
50MG | 88 | In Stock |
|
100MG | 160 | In Stock |
|
200MG | 223 | In Stock |
|
500MG | 358 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVandetanib
-
NoteResearch use only, not for human use.
-
Brief DescriptionVandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.
-
DescriptionVandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.
-
SynonymsZD6474
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR; VEGFR2; VEGFR3
-
Research AreaCancer
-
IndicationThyroid Cancer
Chemical Information
-
CAS Number443913-73-3
-
Formula Weight475.31
-
Molecular FormulaC22H24BrFN4O2
-
Purity>98%(HPLC)
-
SolubilityDMSO: 4 mg/mL (8.41 mM)
-
SMILESCOC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wedge SR, et al. Y Res. 2002, 62(16), 4645-4655.
molnova catalog
related products
-
AZD8931 diFuMaric ac...
AZD8931 is a reversible and ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 (IC50 of 4 nM, 3 nM and 4 nM, respectively).AZD8931 significantly suppressed cell growth of IBC cells and induced apoptosis of human IBC cells in vitro.AZD8931 monotherapy inhibited xenograft growth.
-
Naquotinib mesylate
Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.
-
R162
R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.